The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment
Cancers · 01.05.2025 · 17 (9) · 1546
DOI: 10.3390/cancers17091546 ↗Kurz gefasst
Editorial in der Zeitschrift Cancers, online erschienen am 01.05.2025. Verfasst von Kostas A Papavassiliou und 2 weiteren Autor:innen. Beteiligte Einrichtung: First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In 2015, the U [...]
Autor:innen und Institutionen
- First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Kostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Zitieren
APA
Papavassiliou, K. A., Sofianidi, A. A., & Papavassiliou, A. G. (2025). The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment. Cancers, 17(9), 1546. https://doi.org/10.3390/cancers17091546
Vancouver
Papavassiliou KA, Sofianidi AA, Papavassiliou AG. The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment. Cancers. 2025;17(9):1546. doi:10.3390/cancers17091546
BibTeX
@article{Papavassiliou2025,
author = {Papavassiliou, Kostas A and Sofianidi, Amalia A and Papavassiliou, Athanasios G},
title = {The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment},
journal = {Cancers},
year = {2025},
volume = {17},
number = {9},
pages = {1546},
doi = {10.3390/cancers17091546}
}
EUVIMED